Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Proctor

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Leukemia|August 1, 1991
Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukemiaP G Middleton, R A Prince, I K Williamson, et al.
Leukemia|January 21, 2006
Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemiaR N Sanderson, P R E Johnson, A V Moorman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease controlS J Proctor, A L Lennard, G H Jackson, et al.
Bone Marrow Transplantation|April 1, 1995
Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host diseaseA L Appleton, L Sviland, J S Peiris, et al.
Bone Marrow Transplantation|December 1, 1995
Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport GroupA L Appleton, L Sviland, J S Peiris, et al.
Hematological Oncology|January 1, 1989
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease. A prospective study on behalf of the East of Scotland and Newcastle Lymphoma Group (ESNLG)A L Lennard, S J Proctor, A A Dawson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)S J Proctor, M Mackie, A Dawson, et al.
Leukemia & Lymphoma|November 17, 2006
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trialP R A Taylor, J M White, R J Prescott, et al.
Scottish Medical Journal|December 1, 1988
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphomaR C Leonard, H H Lucraft, S J Proctor, et al.
British Journal of Cancer|February 23, 1999
Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based studyC A Stiller, S Benjamin, R A Cartwright, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Leukemia|August 1, 1991
Alpha interferon gene deletions in adults, children and infants with acute lymphoblastic leukemiaP G Middleton, R A Prince, I K Williamson, et al.
Leukemia|January 21, 2006
Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemiaR N Sanderson, P R E Johnson, A V Moorman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease controlS J Proctor, A L Lennard, G H Jackson, et al.
Bone Marrow Transplantation|April 1, 1995
Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host diseaseA L Appleton, L Sviland, J S Peiris, et al.
Bone Marrow Transplantation|December 1, 1995
Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport GroupA L Appleton, L Sviland, J S Peiris, et al.
Hematological Oncology|January 1, 1989
Lomustine, vindesine and bleomycin (LVB) used in the treatment of relapsed advanced Hodgkin's disease. A prospective study on behalf of the East of Scotland and Newcastle Lymphoma Group (ESNLG)A L Lennard, S J Proctor, A A Dawson, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A population-based study of intensive multi-agent chemotherapy with or without autotransplant for the highest risk Hodgkin's disease patients identified by the Scotland and Newcastle Lymphoma Group (SNLG) prognostic index. A Scotland and Newcastle Lymphoma Group study (SNLG HD III)S J Proctor, M Mackie, A Dawson, et al.
Leukemia & Lymphoma|November 17, 2006
The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trialP R A Taylor, J M White, R J Prescott, et al.
Scottish Medical Journal|December 1, 1988
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphomaR C Leonard, H H Lucraft, S J Proctor, et al.
British Journal of Cancer|February 23, 1999
Patterns of care and survival for adolescents and young adults with acute leukaemia--a population-based studyC A Stiller, S Benjamin, R A Cartwright, et al.
Pageof 20